Equity Profile

ELV

Elevance Health, Inc.

Health CareManaged Health Care$92.3B

Jul16Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Elevance Health, Inc. is a leading managed health care company that provides health insurance and related services....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well Elevance is managing costs and revenues.

$6.21

Revenue

Total revenue reflects the company's overall sales performance and growth trajectory, which is critical for assessing its market position.

$48.6B

Wall Street expectations, options signals, track record, and call prep available with Pro.

ELV Q2-2026 Earnings Preview

Context

Company Snapshot

Elevance Health, Inc. is a leading managed health care company that provides health insurance and related services. As part of the health care sector, it plays a crucial role in managing health care costs and improving patient outcomes, especially in a time when health care access and affordability are major concerns for consumers.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

63%

Avg EPS Surprise

+3.63%

Avg Stock Reaction

-2.37%

Last Quarter Recap

In Q1 2026, Elevance reported an EPS of $12.58, significantly beating estimates by 17.75%. The stock experienced a slight increase of 0.03% the following day, indicating cautious optimism from investors.

Management Promises & Guidance

Continued focus on cost management and operational efficiency.
Commitment to expanding digital health initiatives.
Plans to enhance member engagement and satisfaction.

Expectations

Wall Street Expectations

Analysts expect Elevance to report strong earnings driven by effective cost management and growth in membership. However, there are concerns about potential pressures from regulatory changes and competition.

Bull Case

If Elevance can exceed EPS expectations and show strong revenue growth, it may signal robust demand for its services and effective management strategies.

Bear Case

On the other hand, if the company fails to meet revenue expectations or provides weak guidance, it could raise red flags about its future growth potential.

Key Metrics to Watch

EPS

$6.21

Earnings per share is a key indicator of profitability and will show how well Elevance is managing costs and revenues.

Revenue

$48.6B

Total revenue reflects the company's overall sales performance and growth trajectory, which is critical for assessing its market position.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Elevance's EPS exceed the consensus estimate of $6.21?

A strong EPS could indicate effective cost management and operational efficiency, which are crucial for investor confidence.

What guidance will Elevance provide regarding future revenue growth?

Future revenue guidance will be key to understanding the company's growth trajectory and how it plans to navigate potential market challenges.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may be underestimating Elevance's ability to manage costs effectively in a challenging regulatory environment, which could lead to better-than-expected margins.

Supporting Evidence

Elevance has consistently beaten EPS estimates in recent quarters, indicating strong operational performance.

Options pricing suggests a larger move than historical averages, implying that traders expect significant news.

The company's focus on digital health initiatives may provide a competitive edge that is not fully reflected in current estimates.

Key Risk

If Elevance's revenue growth exceeds $49B, it could significantly shift market sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be closely watched as it could set the tone for the rest of the year, especially in light of recent earnings surprises.

Bull Confirmed If

An EPS of $6.50 or higher would confirm strong operational performance and investor confidence.

Bear Confirmed If

An EPS below $6.06 would raise concerns about profitability and cost management.

Pre-Earnings Positioning

Options Market

Implied Move

±9.58%

Historical Avg

±5.1%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings report.

Options are pricing ±9.6% while ELV has averaged ±5.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

27.9%

Calls (9K)P/C Ratio: 0.54Puts (23K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Elevance beats expectations and raises guidance, history suggests the stock could rise around 0.64% on the following day.

In-Line / Cautious

If results are in line but management is cautious, the stock may see muted reactions, reflecting uncertainty in the market.

Miss

A miss could lead to a decline of around 11.40%, as seen in past quarters when expectations were not met.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on cost management strategies and their impact on margins.
2Insights into membership growth and retention rates.
3Details on digital health initiatives and their expected impact on future revenue.
4Management's outlook on regulatory changes and their potential effects on the business.
5Any commentary on competitive pressures in the managed health care space.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Fastenal Company

Company Snapshot

Elevance Health, Inc. is a leading managed health care company that provides health insurance and related services....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well Elevance is managing costs and revenues.

$6.21

Revenue

Total revenue reflects the company's overall sales performance and growth trajectory, which is critical for assessing its market position.

$48.6B

Wall Street expectations, options signals, track record, and call prep available with Pro.

ELV Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

63%

Avg EPS Surprise

+3.63%

Avg Stock Reaction

-2.37%

Last Quarter Recap

Management Promises & Guidance

Continued focus on cost management and operational efficiency.
Commitment to expanding digital health initiatives.
Plans to enhance member engagement and satisfaction.

Expectations

Wall Street Expectations

Bull Case

If Elevance can exceed EPS expectations and show strong revenue growth, it may signal robust demand for its services and effective management strategies.

Bear Case

On the other hand, if the company fails to meet revenue expectations or provides weak guidance, it could raise red flags about its future growth potential.

Key Metrics to Watch

EPS

$6.21

Earnings per share is a key indicator of profitability and will show how well Elevance is managing costs and revenues.

Revenue

$48.6B

Total revenue reflects the company's overall sales performance and growth trajectory, which is critical for assessing its market position.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Elevance's EPS exceed the consensus estimate of $6.21?

A strong EPS could indicate effective cost management and operational efficiency, which are crucial for investor confidence.

What guidance will Elevance provide regarding future revenue growth?

Future revenue guidance will be key to understanding the company's growth trajectory and how it plans to navigate potential market challenges.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may be underestimating Elevance's ability to manage costs effectively in a challenging regulatory environment, which could lead to better-than-expected margins.

Supporting Evidence

Elevance has consistently beaten EPS estimates in recent quarters, indicating strong operational performance.

Options pricing suggests a larger move than historical averages, implying that traders expect significant news.

The company's focus on digital health initiatives may provide a competitive edge that is not fully reflected in current estimates.

Key Risk

If Elevance's revenue growth exceeds $49B, it could significantly shift market sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be closely watched as it could set the tone for the rest of the year, especially in light of recent earnings surprises.

Bull Confirmed If

An EPS of $6.50 or higher would confirm strong operational performance and investor confidence.

Bear Confirmed If

An EPS below $6.06 would raise concerns about profitability and cost management.

Pre-Earnings Positioning

Options Market

Implied Move

±9.58%

Historical Avg

±5.1%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings report.

Options are pricing ±9.6% while ELV has averaged ±5.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

27.9%

Calls (9K)P/C Ratio: 0.54Puts (23K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Elevance beats expectations and raises guidance, history suggests the stock could rise around 0.64% on the following day.

In-Line / Cautious

If results are in line but management is cautious, the stock may see muted reactions, reflecting uncertainty in the market.

Miss

A miss could lead to a decline of around 11.40%, as seen in past quarters when expectations were not met.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on cost management strategies and their impact on margins.
2Insights into membership growth and retention rates.
3Details on digital health initiatives and their expected impact on future revenue.
4Management's outlook on regulatory changes and their potential effects on the business.
5Any commentary on competitive pressures in the managed health care space.